Delivery Order SPE2DB22D3501-SPE2DB23FTR05
- Not listed
- This federal contract award, valued at $10,681.56, was made by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of GONAL-F RFF REDI-JECT 450 UNIT 0.75ML, a medical product, with a completion date of November 8, 2024. The contract is a Delivery Order with a Firm Fixed Price pricing type. AmerisourceBergen Drug Corp is the prime contractor and holds a...
- This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $11,734.62, is for the delivery of GONAL-F RFF REDI-JECT 450 UNIT 0.75ML medical supplies. It is a firm fixed-price delivery order contract with a completion date of February 4, 2025. The contract is not designated with any set-aside requirements, indicating open competition....
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $16,481.11 firm fixed price delivery order is for the supply of GONAL-F RFF REDI-JECT 900 UNIT 1.5ML, a specialty pharmaceutical product. The award is associated with a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which provides a...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,852.82 firm fixed-price contract is for the supply of GONAL-F RFF REDI-JECT 300 UNIT 0.5ML, a prescription medication. The contract has an ultimate completion date of March 24, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and...
- This federal contract award, valued at $6,930.70, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the delivery of Gonal-F RFF Redi-Ject 900 unit 1.5ml, a pharmaceutical product, with a completion date of June 5, 2024. Amerisourcebergen, a major pharmaceutical distribution company, holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical worth up to $999,999,999.00 through December...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $101,892.98, is for the delivery of Gonal-F RFF Redi-Ject 900 Unit 1.5ML medical supplies. The contract is a Firm Fixed Price delivery order with a performance period extending to February 3, 2025. Amerisourcebergen Drug Corp is a for-profit organization registered in the...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of GONAL-F RFF REDI-JECT 900 UNIT 1.5ML, a pharmaceutical product, with a ceiling value of $136,146.74 and a period of performance through January 16, 2025. The contract is a firm fixed-price delivery order, with no set-aside designation, suggesting open competition....
- This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The contract is for the delivery of GONAL-F RFF REDI-JECT 300 UNIT 0.5ML, a pharmaceutical product. The contract has a firm fixed price of $1,097.52 and a completion date of June 12, 2025. It is not a set-aside contract, indicating open competition. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
- AmerisourceBergen Drug Corp was awarded a delivery order contract valued at $16,462.50 by the Defense Logistics Agency (DLA) Medical Supply Chain on September 8, 2025, for the supply of GONAL-F RFF REDI-JECT 900 Unit 1.44ML, a pharmaceutical product. The contract is structured as a firm fixed-price delivery order with no set-aside designation, indicating competitive award selection. Performance will be executed from the company's corporate office location in Conshohocken, Pennsylvania, with an...
- The Defense Logistics Agency awarded a delivery order valued at $4,146.49 to AmerisourceBergen Drug Corp for GONAL-F RFF REDI-JECT 900 UNIT 1.44ML, a pharmaceutical product. This firm fixed price delivery order, issued on July 31, 2025, with completion targeted for August 1, 2025, represents a child contract under AmerisourceBergen's larger federal contract portfolio. The award utilized no set-aside designation, indicating it was competitively awarded through standard procurement procedures. The...
- SPE2DB22D3501Indefinite Delivery Contract
- SPE2DB22D3501-SPE2DB23FTR05Delivery Order
This federal contract award, with a value of $29,278.80, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of GONAL-F RFF REDI-JECT 900 UNIT 1.5ML, a specialty medication. This order is a Delivery Order under a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 that Amerisourcebergen holds with the DLA Troop Support Medical to provide a comprehensive range of medical commodities, including pharmaceuticals and medical supplies, to support military treatment programs and facilities worldwide. The contract has no set-aside designation and is a Firm Fixed Price arrangement. Amerisourcebergen's extensive federal contracting experience and its position as a leading pharmaceutical distributor enable it to efficiently supply critical medical products to various government agencies and healthcare programs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $29.3k | 11/30/22 |